Chemicals
Chemicals Company Financials
chemicals | company financials
| Market | Report Title | Report Type | Country | Published | Cost |
|
MANNATECH | Company Financials | US | 13/11/09 | £5.00 |
| The Company develops and sells nutritional supplements, topical and skin care products, and weight-management products. | |||||
|
PAR PHARMACEUTICAL COMPANIES | Company Financials | US | 13/11/09 | £5.00 |
| The Company through its subsidiary, Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States. | |||||
|
YOMEISHU SEIZO | Company Financials | Japan | 13/11/09 | £5.00 |
| The Company's principal activities are engaged in the production and sale of Yomeishu, an extracted herbal preparation manufactured by brewing several natural medicinal ingredients. Its products are | |||||
|
CHENGZHI COMPANY | Company Financials | China | 13/11/09 | £5.00 |
| The Group's principal activities are the development, production and sale of life science and technology medicines, biological pharmaceuticals, Chinese and Western medicines and biochemical, health | |||||
|
FENNER | Company Financials | UK | 13/11/09 | £5.00 |
| The Company is a global manufacturer and distributor of conveyor belting and reinforced precision polymer products. | |||||
|
WEIFANG YAXING CHEMICAL | Company Financials | China | 13/11/09 | £5.00 |
| The principal activities of the Company and its subsidiaries are the provision of manufacture and sale of chemical products. It mainly produces and sells chlorinated polyethylene (CPE), caustic | |||||
|
ASIA POLYMER | Company Financials | Taiwan | 13/11/09 | £5.00 |
| The Company is engaged in the manufacture and distribution of low-density polyethylene (LDPE), medium-density polyethylene and ethylene-vinyl acetate (EVA) copolymer. | |||||
|
CLAVIS PHARMA | Company Financials | Norway | 13/11/09 | £5.00 |
| Clavis Pharma ASA is a drug discovery company. It was established in 2001 when Hydro ASA and NeoMed Management spun off their Lipid Vector Technology (LVT) research activities. The Company uses LVT | |||||
|
ACORDA THERAPEUTICS | Company Financials | US | 13/11/09 | £5.00 |
| The Company, a biopharmaceutical company, engages in the identification, development, and commercialization of various therapies for the improvement of neurological functions in people with multiple | |||||
|
HALOZYME THERAPEUTICS | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a biopharmaceutical company dedicated to the development and commercialization of products targeting the extracellular matrix, or Matrix, for the endocrinology, oncology, dermatology | |||||
|
MOLECULAR INSIGHT PHARMACEUTIC | Company Financials | US | 13/11/09 | £5.00 |
| The company is a development stage biopharmaceutical company, engages in the research, development, and commercialization of molecular imaging pharmaceuticals and radiotherapeutics primarily in the | |||||
|
OCEAN PLASTICS | Company Financials | Taiwan | 13/11/09 | £5.00 |
| The Company's principal activities are the manufacture, processing and distribution of polyurethane leathers and the distribution of plastic materials and products. | |||||
|
SHENZHEN ACCORD PHARMACEUTICAL | Company Financials | China | 13/11/09 | £5.00 |
| The Company's principal activities are the research, development, production, wholesale and chain retail of pharmaceuticals. | |||||
|
KMG CHEMICALS | Company Financials | US | 13/11/09 | £5.00 |
| The Company through its subsidiaries, operates in the manufacture and sale of specialty chemicals principally in the United States and internationally. It offers high purity wet process chemicals | |||||
|
OSI PHARMACEUTICALS | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a profitable biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and | |||||
|
PACIFIC ETHANOL | Company Financials | US | 13/11/09 | £5.00 |
| The company produces and markets renewable fuels in the western United States. | |||||
|
BIOMARIN PHARMACEUTICAL | Company Financials | US | 13/11/09 | £5.00 |
| The Company develops and commercializes biopharmaceuticals for serious diseases and medical conditions. | |||||
|
CHEMICAL CO OF MALAYSIA | Company Financials | Malaysia | 13/11/09 | £5.00 |
| The Group is engaged in the manufacture and marketing of agrochemicals, fertilizers, chlor-alkali products, pharmaceuticals and healthcare products, marketing of industrial chemicals and development | |||||
|
YUKI GOSEI KOGYO | Company Financials | Japan | 13/11/09 | £5.00 |
| The Company is a manufacturing company and has four core business segments in their operation There were. The Tobacco Fragrances and Materials segment, The Pharmaceuticals segment, The Food | |||||
|
GREEN PLAINS RENEWABLE ENERGY | Company Financials | US | 13/11/09 | £5.00 |
| The Company was formed in June 2004 to construct and operate dry mill, fuel-grade ethanol production facilities. Ethanol is a renewable, environmentally clean fuel source that is produced at | |||||
|
CHARLES RIVER LABORATORIES | Company Financials | US | 13/11/09 | £5.00 |
| The Company, together with its subsidiaries, provides solutions that advance the drug discovery and development process, including research models and associated services, and outsourced preclinical | |||||
|
INTEGRA LIFESCIENCES HOLDINGS | Company Financials | US | 13/11/09 | £5.00 |
| The Company develops, manufactures and markets medical devices for use in neurotrauma, neurosurgery, plastic and reconstructive surgery and general surgery. | |||||
|
YANTAI WANHUA POLYURETHANES | Company Financials | China | 13/11/09 | £5.00 |
| The Company is principally engaged in the manufacture and supply of polyurethane and related products. It mainly offer isocyanate (MDI) and MDA derived products, including pure MDI and polymerized | |||||
|
TERRA INDUSTRIES | Company Financials | US | 13/11/09 | £5.00 |
| The company is a producer and marketer of nitrogen products serving agricultural and industrial markets. | |||||
|
NPS PHARMACEUTICALS | Company Financials | US | 13/11/09 | £5.00 |
| The Company is a biopharmaceutical company focused on the development of new treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs. | |||||
